UB Paderborn / Katalog / Suche / in CDI

Remdesivir and Acute Renal Failure: A Potential Safety Signal From Disproportionality Analysis of the WHO Safety Database

Clinical pharmacology and therapeutics, 2021-04, Vol.109 (4), p.1021-1024

2021

Volltextzugriff (PDF)

Features of Inflammatory Heart Reactions Following mRNA COVID‐19 Vaccination at a Global Level

Clinical pharmacology and therapeutics, 2022-03, Vol.111 (3), p.605-613

2022

Volltextzugriff (PDF)

Estimates of population‐based incidence of malignant arrhythmias associated with medication use – a narrative review

Fundamental & clinical pharmacology, 2020-08, Vol.34 (4), p.416-417

Drici, Milou‐Daniel

2020

Volltextzugriff (PDF)

Calcitonin gene-related peptide-targeting drugs and Raynaud’s phenomenon: a real-world potential safety signal from the WHO pharmacovigilance database

Journal of headache and pain, 2022-05, Vol.23 (1), p.53-53, Article 53

2022

Volltextzugriff (PDF)

An artificial intelligence algorithm for co‐clustering to help in pharmacovigilance before and during the COVID‐19 pandemic

British journal of clinical pharmacology, 2024-05, Vol.90 (5), p.1258-1267

2024

Volltextzugriff (PDF)

Spontaneous reporting of adverse drug reactions as an outlet for patient dismay? The case of Levothyrox® change of excipients

Fundamental & clinical pharmacology, 2022-06, Vol.36 (3), p.553-562

2022

Volltextzugriff (PDF)

Spontaneous adverse event notifications by patients subsequent to the marketing of a new formulation of Levothyrox® amidst a drug media crisis: atypical profile as compared with other drugs

Fundamental & clinical pharmacology, 2019-08, Vol.33 (4), p.463-470

2019

Volltextzugriff (PDF)

Immune checkpoint inhibitors-induced nephropathy: a French national survey

Cancer Immunology, Immunotherapy, 2021-11, Vol.70 (11), p.3357-3364

2021

Volltextzugriff (PDF)

Triptan overuse during pregnancy: a possible cause of placental hypoperfusion

European journal of clinical pharmacology, 2021-02, Vol.77 (2), p.269-270

2021

Volltextzugriff (PDF)

Insights on the Evidence of Cardiotoxicity of Hydroxychloroquine Prior and During COVID‐19 Epidemic

Clinical and translational science, 2021-01, Vol.14 (1), p.163-169

2021

Volltextzugriff (PDF)

Hypertension induced by serotonin reuptake inhibitors: analysis of two pharmacovigilance databases

Fundamental & clinical pharmacology, 2019-06, Vol.33 (3), p.296-302

2019

Volltextzugriff (PDF)

Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines

European heart journal. Quality of care & clinical outcomes, 2022-03, Vol.8 (2), p.99-103

2022

Volltextzugriff (PDF)

Adverse Drug Reactions of Olanzapine, Clozapine and Loxapine in Children and Youth: A Systematic Pharmacogenetic Review

Pharmaceuticals (Basel, Switzerland), 2022-06, Vol.15 (6), p.749

2022

Volltextzugriff (PDF)

COVID-19 Vaccine-Associated Transient Global Amnesia: A Disproportionality Analysis of the WHO Safety Database

Frontiers in pharmacology, 2022-05, Vol.13, p.909412-909412

2022

Volltextzugriff (PDF)

Are current guidelines adapted for patient eligibility to PrEP? A case report

BMC infectious diseases, 2019-07, Vol.19 (1), p.601-601, Article 601

2019

Volltextzugriff (PDF)

Is anti-factor Xa chromogenic assay for Rivaroxaban appropriate in clinical practice? Advantages and comparative drawbacks

Thrombosis research, 2015-08, Vol.136 (2), p.396-401

2015

Volltextzugriff (PDF)

Dental Adverse Effects of Anti-CD20 Therapies

Neurology and therapy, 2024-06, Vol.13 (3), p.917-930

2024

Volltextzugriff (PDF)

Optimization of Rituximab Therapy in Adult Patients With PLA2R1-Associated Membranous Nephropathy With Artificial Intelligence

Kidney international reports, 2024-01, Vol.9 (1), p.134-144

2024

Volltextzugriff (PDF)

New Strategies for Volume Control in Patients with Diabetes Mellitus, a Narrative Review

Pharmaceutics, 2022-07, Vol.14 (8), p.1569

2022

Volltextzugriff (PDF)

Case Report: Successful Treatment of Steroid-Refractory Immune Checkpoint Inhibitor-Related Pure Red Cell Aplasia With Cyclosporin

Frontiers in oncology, 2020-08, Vol.10, p.1760-1760

2020

Volltextzugriff (PDF)

Antipsychotic Abuse, Dependence, and Withdrawal in the Pediatric Population: A Real-World Disproportionality Analysis

Biomedicines, 2022-11, Vol.10 (11), p.2972

2022

Volltextzugriff (PDF)

“Off-label” use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers

Therapie, 2020-07, Vol.75 (4), p.371-379

2020

Volltextzugriff (PDF)

Cardiovascular risks of atypical antipsychotic drug treatment

Pharmacoepidemiology and drug safety, 2007-08, Vol.16 (8), p.882-890

2007

Volltextzugriff (PDF)

A Hybrid Algorithm Combining Population Pharmacokinetic and Machine Learning for Isavuconazole Exposure Prediction

Pharmaceutical research, 2023-04, Vol.40 (4), p.951-959

2023

Volltextzugriff (PDF)

Medications as a Trigger of Sleep-Related Eating Disorder: A Disproportionality Analysis

Journal of clinical medicine, 2022-07, Vol.11 (13), p.3890

2022

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Remdesivir and Acute Renal Failure: A Potential Safety Signal From Disproportionality Analysis of the WHO Safety Database

Features of Inflammatory Heart Reactions Following mRNA COVID‐19 Vaccination at a Global Level

Estimates of population‐based incidence of malignant arrhythmias associated with medication use – a narrative review

Calcitonin gene-related peptide-targeting drugs and Raynaud’s phenomenon: a real-world potential safety signal from the WHO pharmacovigilance database

An artificial intelligence algorithm for co‐clustering to help in pharmacovigilance before and during the COVID‐19 pandemic

Spontaneous reporting of adverse drug reactions as an outlet for patient dismay? The case of Levothyrox® change of excipients

Spontaneous adverse event notifications by patients subsequent to the marketing of a new formulation of Levothyrox® amidst a drug media crisis: atypical profile as compared with other drugs

Immune checkpoint inhibitors-induced nephropathy: a French national survey

Triptan overuse during pregnancy: a possible cause of placental hypoperfusion

Insights on the Evidence of Cardiotoxicity of Hydroxychloroquine Prior and During COVID‐19 Epidemic

Hypertension induced by serotonin reuptake inhibitors: analysis of two pharmacovigilance databases

Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines

Adverse Drug Reactions of Olanzapine, Clozapine and Loxapine in Children and Youth: A Systematic Pharmacogenetic Review

COVID-19 Vaccine-Associated Transient Global Amnesia: A Disproportionality Analysis of the WHO Safety Database

Are current guidelines adapted for patient eligibility to PrEP? A case report

Is anti-factor Xa chromogenic assay for Rivaroxaban appropriate in clinical practice? Advantages and comparative drawbacks

Dental Adverse Effects of Anti-CD20 Therapies

Optimization of Rituximab Therapy in Adult Patients With PLA2R1-Associated Membranous Nephropathy With Artificial Intelligence

New Strategies for Volume Control in Patients with Diabetes Mellitus, a Narrative Review

Case Report: Successful Treatment of Steroid-Refractory Immune Checkpoint Inhibitor-Related Pure Red Cell Aplasia With Cyclosporin

Antipsychotic Abuse, Dependence, and Withdrawal in the Pediatric Population: A Real-World Disproportionality Analysis

“Off-label” use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers

Cardiovascular risks of atypical antipsychotic drug treatment

A Hybrid Algorithm Combining Population Pharmacokinetic and Machine Learning for Isavuconazole Exposure Prediction

Medications as a Trigger of Sleep-Related Eating Disorder: A Disproportionality Analysis

Suchergebnisse filtern